| Species | Original | Mutated to | Mutation |
| Human | Tyr 89 |
|
|
| Rat Equivalent | Phe 94 | ||
| Mouse Equivalent | Tyr 94 | Phe |
Nine residues (Thr 86, Thr 87, Tyr 88, Ile 89, Tyr 91, Arg 92, Gln 93, Tyr 94, Trp 95) were mutated individually to alanine (alanine scanning mutagenesis). The ligands [3H]granisetron, curare, and serotonin were used to examine the properites of the 5-HT3 binding site.
W90F was analyzed instead of W90A, and it proved to be the only one that significantly affected the interaction of curare with the receptor. R92A was the only substitution that altered the affinity of the agonist serotonin. W90F, R92A, and Y94A all reduced the affinity of [3H]granisetron. The periodicity of the effect suggests the participation of a beta-strand.
Eleven residues (Tyr 50, Tyr 73, Tyr 88, Tyr 91, Tyr 94, Tyr 141, Tyr 143, Tyr 153, Tyr 167, Tyr 234, Tyr 240) were mutated individually for alanine, serine and some residues for phenylalanine. The ligands [3H]granisetron and 5-HT were used to examine the properities of ligand binding sites and function of the 5-HT3A receptor, respectively.
Mouse 5-HT3A receptors were expressed in Xenopus Oocytes (cRNA injection) and studied using two-electrode voltage-clamp technique. HEK293 cells were used in radioligand binding and calcium imaging assays to study the affinity of [3H]granisetron and the potency of 5-HT, respectively.
TheY94A and Y94S mutations did not significantly altered the affinity of the antagonist [3H]granisetron.
| Receptor | [3H]granisetron binding (Kd) | Cell membrane | Calcium imaging (EC50) mM | Electrophysiology (EC50) mM |
| WT | 0.32 +/- 0.035 | ++ | 1.47 +/-0.42 | 2.39 +/- 0.23 |
| Y50F | NB | - | NR | NR |
| Y50A | NB | -/+ | NR | NR |
| Y50S | NB | -/+ | NR | 1.59 +/- 0.18 |
| Y73A/S | YES | NT | NT | NT |
| Y88A/S | YES | NT | NT | NT |
| Y91F | YES | NT | 2.13 +/- 0.51 | 4.22 +/-0.25 |
| Y91A | NO | - | NR | 13.7 +/-1.25* |
| Y91S | NO | + | NR | 57.7 +/-7.16 * |
| Y94A/S | YES | NT | NT | NT |
| Y141F | YES | NT | NT | NT |
| Y141A | YES | NT | NR | NT |
| Y141S | NO | ++ | NR | NT |
| Y143F | YES | NT | NT | NT |
| Y143A | YES | NT | NR | NT |
| Y143S | YES | NT | >500* | NT |
| Y153A | YES | NT | 74.3 +/- 8.9* | NT |
| Y153S | NO | ++ | 59.2 +/- 7.3* | NT |
| Y167A/S | YES | NT | NT | NT |
| Y234F | YES | NT | NT | NT |
| Y234A | NO | ++ | NR | NT |
| Y234S | NO | + | NR | NT |
| Y240A/S | YES | NT | NT | NT |
NT, Not tested
++, Presence of cell surface receptors revealed by immunocytochemistry
-/+, Reduced cell surface receptor expression compared to WT 5-HT3A
-, Absence of cell surface receptors
* significantly different from the WT 5-HT3A receptor
Eleven residues (Tyr 50, Tyr 73, Tyr 88, Tyr 91, Tyr 94, Tyr 141, Tyr 143, Tyr 153, Tyr 167, Tyr 234, Tyr 240) were mutated individually for alanine, serine and some residues for phenylalanine. The ligands [3H]granisetron and 5-HT were used to examine the properities of ligand binding sites and function of the 5-HT3A receptor, respectively.
Mouse 5-HT3A receptors were expressed in Xenopus Oocytes (cRNA injection) and studied using two-electrode voltage-clamp technique. HEK293 cells were used in radioligand binding and calcium imaging assays to study the affinity of [3H]granisetron and the potency of 5-HT, respectively.
TheY94A and Y94S mutations did not significantly altered the affinity of the antagonist [3H]granisetron.
| Receptor | [3H]granisetron binding (Kd) | Cell membrane | Calcium imaging (EC50) mM | Electrophysiology (EC50) mM |
| WT | 0.32 +/- 0.035 | ++ | 1.47 +/-0.42 | 2.39 +/- 0.23 |
| Y50F | NB | - | NR | NR |
| Y50A | NB | -/+ | NR | NR |
| Y50S | NB | -/+ | NR | 1.59 +/- 0.18 |
| Y73A/S | YES | NT | NT | NT |
| Y88A/S | YES | NT | NT | NT |
| Y91F | YES | NT | 2.13 +/- 0.51 | 4.22 +/-0.25 |
| Y91A | NO | - | NR | 13.7 +/-1.25* |
| Y91S | NO | + | NR | 57.7 +/-7.16 * |
| Y94A/S | YES | NT | NT | NT |
| Y141F | YES | NT | NT | NT |
| Y141A | YES | NT | NR | NT |
| Y141S | NO | ++ | NR | NT |
| Y143F | YES | NT | NT | NT |
| Y143A | YES | NT | NR | NT |
| Y143S | YES | NT | >500* | NT |
| Y153A | YES | NT | 74.3 +/- 8.9* | NT |
| Y153S | NO | ++ | 59.2 +/- 7.3* | NT |
| Y167A/S | YES | NT | NT | NT |
| Y234F | YES | NT | NT | NT |
| Y234A | NO | ++ | NR | NT |
| Y234S | NO | + | NR | NT |
| Y240A/S | YES | NT | NT | NT |
NT, Not tested
++, Presence of cell surface receptors revealed by immunocytochemistry
-/+, Reduced cell surface receptor expression compared to WT 5-HT3A
-, Absence of cell surface receptors
* significantly different from the WT 5-HT3A receptor